Skip Navigation
Skip to contents

Diabetes Metab J : Diabetes & Metabolism Journal



Page Path
HOME > Diabetes Metab J > Volume 35(5); 2011 > Article
2011 Clinical Practice Guidelines for Type 2 Diabetes in Korea
Seung-Hyun Ko1, Sung-Rea Kim1, Dong-Joon Kim2, Seung-Joon Oh3, Hye-Jin Lee4, Kang-Hee Shim5, Mi-Hye Woo6, Jun-Young Kim7, Nan-Hee Kim8, Jae-Taik Kim9, Chong Hwa Kim10, Hae Jin Kim11, In-Kyung Jeong3, Eun-Kyung Hong12, Jae-Hyoung Cho1, Ji-Oh Mok13, Kun-Ho Yoon1, Committee of Clinical Practice Guidelines, Korean Diabetes Association
Diabetes & Metabolism Journal 2011;35(5):431-436.
Published online: October 31, 2011
  • 51 Download
  • 99 Crossref
  • 98 Scopus

1Division of Endocrinology & Metabolism, Department of Internal Medicine, The Catholic University of Korea, Seoul, Korea.

2Department of Internal Medicine, Inje University College of Medicine, Goyang, Korea.

3Division of Endocrinology & Metabolism, Department of Internal Medicine, Kyung Hee University School of Medicine, Seoul, Korea.

4Division of Endocrinology, Department of Internal Medicine, Ewha Womans University School of Medicine, Seoul, Korea.

5Department of Diabetes Education, Samsung Medical Center, Seoul, Korea.

6Department of Clinical Nutrition, Kyung Hee University Medical Center, Seoul, Korea.

7Department of Socialwork, Hallym University Kangnam Sacred Heart Hospital, Seoul, Korea.

8Department of Internal Medicine, Korea University College of Medicine, Ansan, Korea.

9Division of Endocrinology and Metabolism, Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea.

10Division of Endicrinology & Metabolism, Sejong General Hospital, Seoul, Korea.

11Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon, Korea.

12Department of Internal Medicine, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea.

13Division of Endocrinology & Metabolism, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Korea.

Corresponding author: Kun-Ho Yoon. Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, 505 Banpo-dong, Seocho-gu, Seoul 137-701, Korea.

Copyright © 2011 Korean Diabetes Association

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

  • As in other countries, type 2 diabetes is major health concern in Korea. A dramatic increase in the prevalence of type 2 diabetes and its chronic complications has led to an increase in health costs and economic burdens. Early detection of high risk individuals, hidden diabetic patients, and improvement in the quality of care for the disease are the first steps to mitigate the increase in prevalence. The Committee of Clinical Practice Guidelines of the Korean Diabetes Association revised and updated the '3rd Clinical Practice Guidelines' at the end of 2010. In the guidelines, the committee recommended active screening of high risk individuals for early detection and added the hemoglobin A1c level to the diagnostic criteria for type 2 diabetes based on clinical studies performed in Korea. Furthermore, the committee members emphasized that integrating patient education and self-management is an essential part of care. The drug treatment algorithm based on the degree of hyperglycemia and patient characteristics were also updated.
The prevalence of type 2 diabetes mellitus in Korea is estimated to be 7.3% (in those over 20 years of age), according to a report by the Korea National Health and Nutrition Examination Survey (KNHNS III, 2005), an approximately five-fold increase from the value 30 years ago [1-3]. The number of patients with type 2 diabetes is expected to increase dramatically from about 3.5 million in 2010 (7.08% of the total population) to about 5.5 million (10.85%) by 2030 [3,4].
The obese and overweight population is also increasing steadily in Korea; in addition, Korea is becoming one of the aged societies in the world. This increase in societal age has contributed to the dramatic increase in type 2 diabetic patients. Furthermore, diabetes mellitus was the fifth leading cause of death in Korea in 2008 [3]. Therefore, the early detection and prevention of type 2 diabetes are major health concerns for Korean people and the government. The diagnosis and appropriate treatment of type 2 diabetes mellitus are very important issues in establishing and implementing high-priority health policies in Korea.
Recently, several hospital-based or community-based cross-sectional and cohort studies undertaken in Korea have been published. In 2007, the Committee of the Korean Diabetes Association (KDA) on the Diagnosis and Classification of Diabetes Mellitus analyzed four of these community-based epidemiological studies performed after 1990, which included 6,234 subjects, to demonstrate the diagnostic equivalence of fasting plasma glucose (FPG) value to a 2-hour plasma glucose (PG) value range of 140 and 200 mg/dL. From a receiver operating characteristic (ROC) analysis, an FPG cutoff of 110 mg/dL corresponded to a 2-hour PG value of 200 mg/dL (sensitivity 76.4%, specificity 92.2%) [5]. The optimal cutoff point for FPG for the diagnosis of impaired glucose tolerance (IGT) in Korean people was 97 mg/dL (sensitivity 57.5%, specificity 71.0%). Another study that compared the FPG criterion for diagnostic screening of diabetes with the 2-hour PG criterion in 1,731 middle-aged Korean adults showed that the level of agreement between the two diagnostic criteria was low (0.268). An ROC analysis determined that an FPG of 100 mg/dL yielded optimal sensitivity and specificity and corresponded to a 2-hour PG result of 200 mg/dL [6]. If these lower cutoff values are applied to the diagnosis of diabetes, the prevalence of diabetes is more than two-fold higher than when the 2-hour PG level of 200 mg/dL is used.
This large discrepancy between the FPG and 2-hour PG criteria in the diagnosis of diabetes and IGT in Koreans is cause for hesitation before changing the diagnostic criteria for diabetes. We also suggest that the FPG level required for a diagnosis of type 2 diabetes mellitus is lower in the Korean and Asian populations than in Western populations [5]. For this reason, Oh et al. [7] analyzed the IFG population according to fasting glucose level, as follows: stage 1 IFG (100 to 109 mg/dL) and stage 2 IFG (110 to 125 mg/dL). For subjects in the stage 2 group, poorer metabolic profiles were detected in terms of total cholesterol, triglyceride, and high blood pressure. Moreover, a greater proportion of people in the stage 2 group were diagnosed with diabetes based on the oral glucose tolerance test (OGTT). From these results, we suggest that Korean individuals with stage 2 IFG should be treated or screened in a different manner from those with stage 1 IFG. To avoid missing further cases of diabetes, the OGTT should be actively recommended for all individuals with stage 2 IFG. However, in patients with stage 1 IFG, additional risk factors for diabetes should be assessed and an annual glucose test be performed (Table 1).
The diagnostic criteria for type 2 diabetes are based on the results of either the fasting or 2-hour 75 g OGTT, according to the observed association between glucose level and the presence of retinopathy. Until now, there have been no cross-sectional epidemiological studies of Koreans to demonstrate an association between PG level and the development of diabetic retinopathy. The KDA has adopted the diagnostic criteria for type 2 diabetes of the American Diabetes Association (ADA) (Table 2). Moreover, the variable association between FPG and 2-hour PG level between populations must be attributed to different genetic or environmental backgrounds across different ethnic groups. Therefore, more large epidemiological studies are required to confirm the suitable cutoff values for the Korean population.
Oral glucose tolerance test (OGTT)
The OGTT has low repeatability, requires more time and blood samples, and is more expensive than the FPG test. It has not been used to screen for type 2 diabetes mellitus and is not recommended for the diagnosis of type 2 diabetes in routine clinical practice in Korea. However, although FPG is a simple and convenient method, a considerable number of type 2 diabetic patients cannot be diagnosed based on FPG results alone, as discussed above. Several previous studies have shown that the FPG criterion is less sensitive for the detection of diabetes in elderly Korean people than the OGTT-based criterion [8-10]. Therefore, the OGTT remains a valuable test in the diagnosis of diabetes and the classification of IGT, especially in elderly Koreans. Moreover, OGTT should particularly be considered if the subject has a history of impaired fasting glucose, is a high-risk individual, is pregnant, or to exclude an IGT state.
Hemoglobin A1c (HbA1c)
HbA1c is the gold standard index for follow-up of glycemic control. In addition to its role in monitoring and targeting glycemic control, HbA1c has received attention as a diagnostic criterion for type 2 diabetes since the ADA included a HbA1c value threshold ≥6.5% as a factor with which to diagnose diabetes [11]. If we are to consider HbA1c level as a diagnostic criterion, priority must be given to standardization of the assay method.
A second consensus meeting on the worldwide standardization of the HbA1c measurement, which included the ADA, the European Association for the Study of Diabetes, the International Diabetes Federation, the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC), and the International Society for Pediatric and Adolescent Diabetes, stated that the IFCC reference system for HbA1c represents the only valid method to standardize the measurement [12]. The ADA recommends that HbA1c should be measured according to the method certified by the National Glycohemoglobin Standardization Program and standardized or traceable to the Diabetes Control and Complication Trial reference assay [11]. Because the HbA1c assay was not standardized throughout the country, HbA1c was not recommended as a diagnostic criterion for diabetes mellitus in Korea until 2007. However, HbA1c standardization has been widely performed since 2007 by the Korean Association of Quality Assurance for Clinical Laboratory, the Metabolic Disorders Subcommittee, the Korean Society of Laboratory Medicine, and the KDA, including a nation-wide survey for the current status of the HbA1c test [13]. Most commercial laboratories in Korea are certified by Designated Comparison Methods, and accuracy-based proficiency tests are underway. Based on this background, we included HbA1c as a diagnostic criterion and renewed our clinical practice guidelines in 2011.
Several studies have been performed in Korea to determine the cutoff point for HbA1c required to predict an abnormal glucose tolerance status in non-diabetic Korean subjects. Bae et al. [14] analyzed 1,482 subjects without diabetes and reported a cutoff point of 5.95% HbA1c to predict diabetes, with a sensitivity of 60.8% and specificity of 85.6%. One study that included 392 subjects with risk factors for diabetes showed that the current guideline of FPG ≥126 mg/dL for diabetes screening detected only 55.7% of diabetic subjects. The optimal cutoff points for HbA1c and FPG for the diagnosis of diabetes were 6.1% (sensitivity 81.8%, specificity 84.9%) and 110 mg/dL (sensitivity 85.2%, specificity 88.5%), respectively [15]. Ku et al. [16] reported a cutoff point for HbA1c derived from the data collected from 19,178 subjects without diabetes. When the FPG criterion was used, the cutoff value was 5.9% (sensitivity 84.6%, specificity 85.9%), and when the 2-hour glucose level after OGTT was used, the cutoff value was 6.1% (sensitivity 86.5%, specificity 85.8%).
Based on these clinical results, we suggest that the HbA1c cutoff level should be lower than the ADA criterion. However, larger epidemiological studies are required to confirm the suitable cutoff values for the Korean population.
Large prospective, randomized controlled clinical trials such as the Kumamoto study [17] and the UK Prospective Diabetes Study (UKPDS) [18,19] have showed that early intensive glycemic control in type 2 diabetic patients significantly reduced microvascular and macrovascular diabetic complications. Based on these results, most of the clinical practice guidelines for glycemic control target of type 2 diabetes since early the 2000s have recommend the achievement of near-normoglycemia to prevent diabetic vascular complications. However, three recently published large RCT studies (ACCORD, ADVANCE, VADT) have demonstrated no significant benefits in cardiovascular outcome with intensive glycemic control in type 2 diabetes [20]. From these findings, we agreed not to overlook the potential risks of very strict glycemic control in specific situations, such as old age with long diabetic duration, combined severe complications, recurrent severe hypoglycemic episodes, or limited life expectancy. However, it should be kept in mind that many meta-analysis consistently provide evidence for the clinical benefits of achieving and maintaining intensive glycemic control to prevent diabetic complications. Therefore, a glycemic goal of HbA1c ≤6.5% should be attained, especially in the recently diagnosed, young type 2 diabetic patients without severe complications or hypoglycemia through lifestyle modification and glucose-lowering agents, including insulin (Table 3, Fig. 1).
In addition to glycemic control within the target range, the comprehensive management of metabolic risk factors is also clinically important. After diagnosis of type 2 diabetes, lifestyle modification, as well as medical treatment, should be emphasized to prevent cardiovascular events. Lifestyle modification could be accomplished by diabetes self-management education, including knowledge, self-care behavior, self monitoring of blood glucose, medical nutrition therapy, exercise, and hypoglycemia. Blood pressure and dyslipidemia should be normalized by lifestyle modification and anti-hypertensive or lipid-lowering agents. Regular screening for diabetic microvascular or macrovascular complications should be performed (Table 4).
The dramatic increase in the prevalence of type 2 diabetes and its accompanying acute or chronic complications are major health concerns in Korea. Screening of high risk individuals, early detection, and proper management of type 2 diabetes are urgently needed. Although more evidence and clinical trials should be undertaken, appropriate clinical practice guidelines characterized in Korean people with type 2 diabetes have been developed and updated to provide better glycemic control and favorable clinical outcomes.

No potential conflict of interest relevant to this article was reported.

  • 1. Yoon KH, Lee JH, Kim JW, Cho JH, Choi YH, Ko SH, Zimmet P, Son HY. Epidemic obesity and type 2 diabetes in Asia. Lancet 2006;368:1681-1688. ArticlePubMed
  • 2. Kim DJ. The epidemiology of diabetes in Korea. Diabetes Metab J 2011;35:303-308. ArticlePubMedPMC
  • 3. Statistics Korea: 2009 statistical results about cause of death updated 2011 Sep 5. Available from:
  • 4. Task Force Team for Basic Statistical Study of Korean Diabetes Mellitus. Report of Task Force Team for Basic Statistical Study of Korean Diabetes Mellitus: diabetes in Korea 2007. 2007. 1st ed. Seoul: Goldfishery.
  • 5. Oh JY, Lim S, Kim DJ, Kim NH, Kim DJ, Moon SD, Jang HC, Cho YM, Song KH, Park KS. Committee of the Korean Diabetes Association on the Diagnosis and Classification of Diabetes Mellitus. The diagnosis of diabetes mellitus in Korea: a pooled analysis of four community-based cohort studies. Diabet Med 2007;24:217-218. ArticlePubMed
  • 6. Kim JH, Han MA, Park CJ, Park IG, Shin JH, Kim SY, Ryu SY, Bae HY. Evaluation of fasting plasma glucose as a screening for diabetes mellitus in middle-aged adults of Naju Country. Korean Diabetes J 2008;32:328-337.Article
  • 7. Oh JY, Lim S, Kim DJ, Kim NH, Kim DJ, Moon SD, Jang HC, Cho YM, Song KH, Ahn CW, Sung YA, Park JY, Shin C, Lee HK, Park KS. Committee of the Korean Diabetes Association on the Diagnosis and Classification of Diabetes Mellitus. A report on the diagnosis of intermediate hyperglycemia in Korea: a pooled analysis of four community-based cohort studies. Diabetes Res Clin Pract 2008;80:463-468. ArticlePubMed
  • 8. Choi KM, Lee J, Kim DR, Kim SK, Shin DH, Kim NH, Park IB, Choi DS, Baik SH. Comparison of ADA and WHO criteria for the diagnosis of diabetes in elderly Koreans. Diabet Med 2002;19:853-857. ArticlePubMed
  • 9. Choi YH, Yoon KH, Cha BY, Lee KW, Son HY, Kang SK. Classification of diabetes mellitus according to NDDG and ADA diagnostic criteria and comparison of insulin secretion. Paper presented at: The 50th Annual Conference of the Korean Association of Internal Medicine 1998 Oct 23-24; Seoul, Korea.
  • 10. Kim DJ, Song KE, Park JW, Cho HK, Lee KW, Huh KB. Clinical characteristics of Korean type 2 diabetic patients in 2005. Diabetes Res Clin Pract 2007;77(Suppl 1):S252-S257. ArticlePubMed
  • 11. American Diabetes Association. Standards of medical care in diabetes--2010. Diabetes Care 2010;33(Suppl 1):S11-S61. ArticlePubMedPMCPDF
  • 12. Hanas R, John G. International HbA1c Consensus Committee. 2010 consensus statement on the worldwide standardization of the hemoglobin A1C measurement. Diabetes Care 2010;33:1903-1904. ArticlePubMedPMCPDF
  • 13. Song J, Kwon KC, Kim JH, Kim JW, Min WK, Lee SY, Lee EH, Jun SH, Choi TY. Annual report on external quality assessment in metabolic disorders in Korea (2008). J Lab Med Qual Assur 2009;31:143-159.
  • 14. Bae JC, Rhee EJ, Choi ES, Kim JH, Kim WJ, Yoo SH, Park SE, Park CY, Lee WY, Oh KW, Park SW, Kim SW. The cutoff value of HbA1c in predicting diabetes in Korean adults in a university hospital in Seoul. Korean Diabetes J 2009;33:503-510.Article
  • 15. Kim KS, Kim SK, Lee YK, Park SW, Cho YW. Diagnostic value of glycated haemoglobin HbA(1c) for the early detection of diabetes in high-risk subjects. Diabet Med 2008;25:997-1000. ArticlePubMed
  • 16. Ku YH, Yoo SH, Jung HS, Lim S, Moon MK, Choi SH, Jang HC, Park KS, Kim SY, Lee HK, Cho YM. Diagnostic value of HbA1c different clinical setting with different prevelence of diabetes mellitus. Korean Diabetes J 2008;32(Suppl 8):S311.
  • 17. Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, Kojima Y, Furuyoshi N, Shichiri M. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 1995;28:103-117. ArticlePubMed
  • 18. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998;352:854-865. ArticlePubMed
  • 19. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-853. ArticlePubMed
  • 20. Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EA, Howard BV, Kirkman MS, Kosiborod M, Reaven P, Sherwin RS. American Diabetes Association. American College of Cardiology Foundation. American Heart Association. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Diabetes Care 2009;32:187-192. ArticlePubMedPMCPDF
Fig. 1
Algorithm for the medical management of type 2 diabetes. OHA, oral hypoglycemic agent; CHF, congestive heart failure.
Table 1
Screening of type 2 diabetes

OGTT, oral glucose tolerance test; FPG, fasting plasma glucose.

Table 2
Diagnostic criteria for type 2 diabetes in Korea

Normal activity should be maintained for at least three days before sampling. In the absence of unequivocal hyperglycemia, blood sampling should be repeated.

FPG, fasting plasma glucose. "Fasting" means no caloric intake for at least 8 hours; PG, plasma glucose.

aGlucose load containing the equivalent of 75 g of anhydrous glucose dissolved in water, b"Random" is defined as without regard to the time since the last meal.

Table 3
Recommendation of glycemic target in patients with type 2 diabetes

FPG, fasting plasma glucose.

Table 4
Recommendations for comprehensive management of individuals with type 2 diabetes

LDL-C, low density lipoprotein cholesterol; HDL-C, high density lipoprotein cholesterol.

Figure & Data



    Citations to this article as recorded by  
    • Paradigm Shift in Management of Hyperglycemia in Patients with Type 2 Diabetes: Glucocentric versus Organ Protection
      Jong Chul Won
      The Journal of Korean Diabetes.2023; 24(2): 59.     CrossRef
    • Association of HbA1c with functional outcome by ischemic stroke subtypes and age
      Jihyun Jeong, Jae Kyung Park, Young Ho Koh, Jong-Moo Park, Hee-Joon Bae, Sang-Moon Yun
      Frontiers in Neurology.2023;[Epub]     CrossRef
    • Current Status of Low-Density Lipoprotein Cholesterol Target Achievement in Patients with Type 2 Diabetes Mellitus in Korea Compared with Recent Guidelines
      Soo Jin Yun, In-Kyung Jeong, Jin-Hye Cha, Juneyoung Lee, Ho Chan Cho, Sung Hee Choi, SungWan Chun, Hyun Jeong Jeon, Ho-Cheol Kang, Sang Soo Kim, Seung-Hyun Ko, Gwanpyo Koh, Su Kyoung Kwon, Jae Hyuk Lee, Min Kyong Moon, Junghyun Noh, Cheol-Young Park, Sung
      Diabetes & Metabolism Journal.2022; 46(3): 464.     CrossRef
    • Correlation between Serum Osmolarity and Creatinine in Health Check-Up Subjects (Examinees) with Diabetes
      Mi-Kyung Park, Geum-Seon Lee, Sun-Hee Kim, Mi-Eun Yun
      The Korean Journal of Community Living Science.2022; 33(2): 237.     CrossRef
    • Dietary antioxidant consumption and the risk of type 2 diabetes in South Korean adults: a prospective cohort study based on the Health Examinees study
      Li-Juan Tan, Su Bin Hwang, Shinyoung Jun, Hyojee Joung, Sangah Shin
      BMJ Open.2022; 12(7): e065073.     CrossRef
    • Investigating the Effectiveness of Very Low-Calorie Diets and Low-Fat Vegan Diets on Weight and Glycemic Markers in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis
      Anjali Kashyap, Alexander Mackay, Ben Carter, Claire L. Fyfe, Alexandra M. Johnstone, Phyo K. Myint
      Nutrients.2022; 14(22): 4870.     CrossRef
    • Screening for Prediabetes and Diabetes in Korean Nonpregnant Adults: A Position Statement of the Korean Diabetes Association, 2022
      Kyung Ae Lee, Dae Jung Kim, Kyungdo Han, Suk Chon, Min Kyong Moon
      Diabetes & Metabolism Journal.2022; 46(6): 819.     CrossRef
    • Mobile Healthcare System Provided by Primary Care Physicians Improves Quality of Diabetes Care
      Tae Jung Oh, Jie-Eun Lee, Seok Kim, Sooyoung Yoo, Hak Chul Jang
      CardioMetabolic Syndrome Journal.2021; 1(1): 88.     CrossRef
    • Treatment Patterns of Type 2 Diabetes Assessed Using a Common Data Model Based on Electronic Health Records of 2000–2019
      Kyung Ae Lee, Heung Yong Jin, Yu Ji Kim, Yong-Jin Im, Eun-Young Kim, Tae Sun Park
      Journal of Korean Medical Science.2021;[Epub]     CrossRef
    • A Review on Metformin: Clinical Significance and Side Effects
      Mazumder Avijit, Singh Ashini
      Research Journal of Pharmacy and Technology.2021; : 6179.     CrossRef
    • Cardiovascular Disease among Patients with Diabetes: The Current Scenario in Saudi Arabia
      Asirvatham Alwin Robert, Mohamed Abdulaziz Al Dawish
      Current Diabetes Reviews.2021; 17(2): 180.     CrossRef
    • Association of Cardiometabolic Multimorbidity Pattern with Dietary Factors among Adults in South Korea
      Dawoon Jeong, Jieun Kim, Hansongyi Lee, Do-Yeon Kim, Hyunjung Lim
      Nutrients.2020; 12(9): 2730.     CrossRef
    • Comparison of effectiveness and drug cost between dipeptidyl peptidase‐4 inhibitor and biguanide as the first‐line anti‐hyperglycaemic medication among Japanese working generation with type 2 diabetes
      Noriko Ihana‐Sugiyama, Takehiro Sugiyama, Hirokazu Tanaka, Kohjiro Ueki, Yasuki Kobayashi, Mitsuru Ohsugi
      Journal of Evaluation in Clinical Practice.2020; 26(1): 299.     CrossRef
    • Exploration of suitable pharmacodynamic parameters for acarbose bioequivalence evaluation: A series of clinical trials with branded acarbose
      Jie Huang, Wen‐yu Liu, Jing‐jing Yu, Jin‐bo Yang, Min Li, Chan Zou, Cheng‐xian Guo, Xiao‐yan Yang, Shuang Yang, Jin‐lian Xie, Zhi‐jun Huang, Hui Chen, Qi Pei, Guo‐ping Yang
      British Journal of Clinical Pharmacology.2020; 86(11): 2225.     CrossRef
    • Sex-, Age-, and Metabolic Disorder-Dependent Distributions of Selected Inflammatory Biomarkers among Community-Dwelling Adults
      So Mi Jemma Cho, Hokyou Lee, Jee-Seon Shim, Hyeon Chang Kim
      Diabetes & Metabolism Journal.2020; 44(5): 711.     CrossRef
    • Efficacy and safety of insulin glargine 300 U/mL versus insulin glargine 100 U/mL in Asia Pacific insulin‐naïve people with type 2 diabetes: The EDITION AP randomized controlled trial
      Linong Ji, Eun Seok Kang, XiaoLin Dong, Ling Li, GuoYue Yuan, Shuhua Shang, Elisabeth Niemoeller
      Diabetes, Obesity and Metabolism.2020; 22(4): 612.     CrossRef
    • Effect of different dietary patterns on glycemic control in individuals with type 2 diabetes mellitus: A systematic review
      Gabrielli Barbosa de Carvalho, Natalia Lohayne Dias-Vasconcelos, Ramara Kadija Fonseca Santos, Paula Nascimento Brandão-Lima, Danielle Góes da Silva, Liliane Viana Pires
      Critical Reviews in Food Science and Nutrition.2020; 60(12): 1999.     CrossRef
    • Clinical Characteristics and Prevalence of Comorbidities according to Metformin Use in Korean Patients with Type 2 Diabetes
      Sang Ouk Chin, In Gyoon Ha, Sang Youl Rhee, Su Jin Jeong, Suk Chon, Sung Hoon Kim, Kyu Jeung Ahn, Sei Hyun Baik, Yongsoo Park, Moon Suk Nam, Kwan Woo Lee, Jeong Taek Woo
      International Journal of Endocrinology.2020; 2020: 1.     CrossRef
    • Chronic Hyperglycemia before Spinal Cord Injury Increases Inflammatory Reaction and Astrogliosis after Injury: Human and Rat Studies
      Ki-Su Park, Jin Bum Kim, Martin Keung, Ye Jin Seo, Sung Young Seo, Seul Ah Mun, Young-Seok Lee, Dae-Chul Cho, Jeong-Hyun Hwang, Inbo Han, Chi Heon Kim, Kyoung-Tae Kim
      Journal of Neurotrauma.2020; 37(9): 1165.     CrossRef
    • National trends in metformin-based combination therapy of oral hypoglycaemic agents for type 2 diabetes mellitus
      Jisu Kim, Susin Park, Hyunsoo Kim, Nam Kyung Je
      European Journal of Clinical Pharmacology.2019; 75(12): 1723.     CrossRef
    • Three-Dimensional Paper-Based Microfluidic Analytical Devices Integrated with a Plasma Separation Membrane for the Detection of Biomarkers in Whole Blood
      Chanyong Park, Hong-Rae Kim, Soo-Kyung Kim, In-Kyung Jeong, Jae-Chul Pyun, Sungsu Park
      ACS Applied Materials & Interfaces.2019; 11(40): 36428.     CrossRef
    • The Effect of Metformin on Prognosis in Patients With Locally Advanced Gastric Cancer Associated With Type 2 Diabetes Mellitus
      Ho Seok Seo, Yoon Ju Jung, Ji Hyun Kim, Han Hong Lee, Cho Hyun Park
      American Journal of Clinical Oncology.2019; 42(12): 909.     CrossRef
    • Discordance in prediction for prognosis of type 2 diabetes after metabolic surgery: comparison of the ABCD, DiaRem, and individualized metabolic surgery models
      Jane Ha, Yeongkeun Kwon, Nam Hoon Kim, Sungsoo Park, Emanuele Lo Menzo, Raul J. Rosenthal
      Annals of Surgical Treatment and Research.2019; 97(6): 309.     CrossRef
    • Discrepancies between Glycosylated Hemoglobin and Fasting Plasma Glucose for Diagnosing Impaired Fasting Glucose and Diabetes Mellitus in Korean Youth and Young Adults
      Jieun Lee, Young Ah Lee, Jae Hyun Kim, Seong Yong Lee, Choong Ho Shin, Sei Won Yang
      Diabetes & Metabolism Journal.2019; 43(2): 174.     CrossRef
    • 2019 Clinical Practice Guidelines for Type 2 Diabetes Mellitus in Korea
      Mee Kyoung Kim, Seung-Hyun Ko, Bo-Yeon Kim, Eun Seok Kang, Junghyun Noh, Soo-Kyung Kim, Seok-O Park, Kyu Yeon Hur, Suk Chon, Min Kyong Moon, Nan-Hee Kim, Sang Yong Kim, Sang Youl Rhee, Kang-Woo Lee, Jae Hyeon Kim, Eun-Jung Rhee, SungWan Chun, Sung Hoon Yu
      Diabetes & Metabolism Journal.2019; 43(4): 398.     CrossRef
    • Lack of Association between Past Helicobacter pylori Infection and Diabetes: A Two-Cohort Study
      Jeung Hui Pyo, Hyuk Lee, Sung Chul Choi, Soo Jin Cho, Yoon-Ho Choi, Yang Won Min, Byung-Hoon Min, Jun Haeng Lee, Heejin Yoo, Kyunga Kim, Jae J. Kim
      Nutrients.2019; 11(8): 1874.     CrossRef
    • Does Korean diet based on brown rice really have the effect on treating chronic diseases and on suspending drug use?
      Su Jin Jung, Baik Hwan Cho, Soo Wan Chae
      Journal of Ethnic Foods.2018;[Epub]     CrossRef
    • The effectiveness, reproducibility, and durability of tailored mobile coaching on diabetes management in policyholders: A randomized, controlled, open-label study
      Da Young Lee, Jeongwoon Park, Dooah Choi, Hong-Yup Ahn, Sung-Woo Park, Cheol-Young Park
      Scientific Reports.2018;[Epub]     CrossRef
    • Clinical Characteristics of People with Newly Diagnosed Type 2 Diabetes between 2015 and 2016: Difference by Age and Body Mass Index
      Kyoung Hwa Ha, Cheol Young Park, In Kyung Jeong, Hyun Jin Kim, Sang-Yong Kim, Won Jun Kim, Ji Sung Yoon, In Joo Kim, Dae Jung Kim, Sungrae Kim
      Diabetes & Metabolism Journal.2018; 42(2): 137.     CrossRef
    • Distribution of glycated haemoglobin and its determinants in Korean youth and young adults: a nationwide population-based study
      Ji-Young Seo, Seung-sik Hwang, Jae Hyun Kim, Young Ah Lee, Seong Yong Lee, Choong Ho Shin, Sei Won Yang
      Scientific Reports.2018;[Epub]     CrossRef
    • The relationship between age of onset and risk factors including family history and life style in Korean population with type 2 diabetes mellitus
      Jin-Won Noh, Jin Hee Jung, Jeong Eun Park, Jung Hwa Lee, Kang Hee Sim, Jumin Park, Min Hee Kim, Ki-Bong Yoo
      Journal of Physical Therapy Science.2018; 30(2): 201.     CrossRef
    • Diabetes Fact Sheet in Korea, 2016: An Appraisal of Current Status
      Jong Chul Won, Jae Hyuk Lee, Jae Hyeon Kim, Eun Seok Kang, Kyu Chang Won, Dae Jung Kim, Moon-Kyu Lee
      Diabetes & Metabolism Journal.2018; 42(5): 415.     CrossRef
    • Features of Long-Standing Korean Type 2 Diabetes Mellitus Patients with Diabetic Retinopathy: A Study Based on Standardized Clinical Data
      Sejeong Park, Sang Youl Rhee, Su Jin Jeong, Kiyoung Kim, Suk Chon, Seung-Young Yu, Jeong-Taek Woo
      Diabetes & Metabolism Journal.2017; 41(5): 393.     CrossRef
    • Letter: Comparison of Age of Onset and Frequency of Diabetic Complications in the Very Elderly Patients with Type 2 Diabetes (Endocrinol Metab2016;31:416-23, Bong-Ki Lee et al.)
      Mee Kyoung Kim
      Endocrinology and Metabolism.2017; 32(1): 140.     CrossRef
    • The Cutoff Value of HbA1c in Predicting Diabetes and Impaired Fasting Glucose
      Seyoung Kwon, Youngak Na
      The Korean Journal of Clinical Laboratory Science.2017; 49(2): 114.     CrossRef
    • Changes in HbA 1c levels and body mass index after successful decompression surgery in patients with type 2 diabetes mellitus and lumbar spinal stenosis: results of a 2-year follow-up study
      Kyoung-Tae Kim, Dae-Chul Cho, Joo-Kyung Sung, Chi Heon Kim, Hyun Kang, Du Hwan Kim
      The Spine Journal.2017; 17(2): 203.     CrossRef
    • Validation of a Newly Developed Equation for Estimating Serum Apolipoprotein B: Associations with Cardiovascular Disease Surrogate Markers in Koreans
      Jong-Dai Kim, You-Cheol Hwang, Hong-Yup Ahn, Cheol-Young Park
      Yonsei Medical Journal.2017; 58(5): 975.     CrossRef
    • Antihyperglycemic agent therapy for adult patients with type 2 diabetes mellitus 2017: a position statement of the Korean Diabetes Association
      Seung-Hyun Ko, Kyu-Yeon Hur, Sang Youl Rhee, Nan-Hee Kim, Min Kyong Moon, Seok-O Park, Byung-Wan Lee, Hyun Jin Kim, Kyung Mook Choi, Jin Hwa Kim
      The Korean Journal of Internal Medicine.2017; 32(6): 947.     CrossRef
    • Diagnostic criteria for diabetes in China: are we pushing too much beyond evidence?
      X Ma, Y-L Zhang, Q Ji, Y Xing, H Pan, S Chen, J-L Tang, S Zhu
      European Journal of Clinical Nutrition.2017; 71(7): 812.     CrossRef
    • Patterns, control and complications of diabetes from a hospital based registry established in a low income country
      Jaweed Akhter, Asma Ahmed, Minaz Mawani, Laila Lakhani, Ayaz Kalsekar, Shehla Tabassum, Najmul Islam
      BMC Endocrine Disorders.2017;[Epub]     CrossRef
    • Analyses of gut microbiota and plasma bile acids enable stratification of patients for antidiabetic treatment
      Yanyun Gu, Xiaokai Wang, Junhua Li, Yifei Zhang, Huanzi Zhong, Ruixin Liu, Dongya Zhang, Qiang Feng, Xiaoyan Xie, Jie Hong, Huahui Ren, Wei Liu, Jing Ma, Qing Su, Hongmei Zhang, Jialin Yang, Xiaoling Wang, Xinjie Zhao, Weiqiong Gu, Yufang Bi, Yongde Peng,
      Nature Communications.2017;[Epub]     CrossRef
    • Antihyperglycemic Agent Therapy for Adult Patients with Type 2 Diabetes Mellitus 2017: A Position Statement of the Korean Diabetes Association
      Seung-Hyun Ko, Kyu-Yeon Hur, Sang Youl Rhee, Nan-Hee Kim, Min Kyong Moon, Seok-O Park, Byung-Wan Lee, Hyun Jin Kim, Kyung Mook Choi, Jin Hwa Kim
      Diabetes & Metabolism Journal.2017; 41(5): 337.     CrossRef
    • Regional variations in frequency of glycosylated hemoglobin (HbA1c) monitoring in Korea: A multilevel analysis of nationwide data
      Kyoung-Hun Yoo, Dong-Wook Shin, Mi-Hee Cho, Sang-Hyuck Kim, Hyun-Jung Bahk, Shin-Hye Kim, Su-Min Jeong, Jae-Moon Yun, Jin-Ho Park, Heesun Kim, BeLong Cho
      Diabetes Research and Clinical Practice.2017; 131: 61.     CrossRef
    • Fasting plasma glucose concentrations for specified HbA1c goals in Korean populations: data from the Fifth Korea National Health and Nutrition Examination Survey (KNHANES V-2, 2011)
      Sangmo Hong, Jun Goo Kang, Chul Sik Kim, Seong Jin Lee, Chang Beom Lee, Sung-Hee Ihm
      Diabetology & Metabolic Syndrome.2016;[Epub]     CrossRef
    • Metabolic syndrome independently predicts future diabetes in women with a history of gestational diabetes mellitus
      Nam H. Cho, Chang Ho Ahn, Joon Ho Moon, Soo Heon Kwak, Sung Hee Choi, Soo Lim, Kyong Soo Park, Boyd E. Metzger, Hak C. Jang
      Medicine.2016; 95(35): e4582.     CrossRef
    • Feasibility of a Patient-Centered, Smartphone-Based, Diabetes Care System: A Pilot Study
      Eun Ky Kim, Soo Heon Kwak, Seungsu Baek, Seung Lyeol Lee, Hak Chul Jang, Kyong Soo Park, Young Min Cho
      Diabetes & Metabolism Journal.2016; 40(3): 192.     CrossRef
    • Effectiveness of Web-Based Interventions for Managing Diabetes in Korea
      Jee Young Joo
      CIN: Computers, Informatics, Nursing.2016; 34(12): 587.     CrossRef
    • Severe Hypoglycemia and Cardiovascular or All-Cause Mortality in Patients with Type 2 Diabetes
      Seon-Ah Cha, Jae-Seung Yun, Tae-Seok Lim, Seawon Hwang, Eun-Jung Yim, Ki-Ho Song, Ki-Dong Yoo, Yong-Moon Park, Yu-Bae Ahn, Seung-Hyun Ko
      Diabetes & Metabolism Journal.2016; 40(3): 202.     CrossRef
    • A Potential Issue with Screening Prediabetes or Diabetes Using Serum Glucose: A Delay in Diagnosis
      Jun Goo Kang, Cheol-Young Park, Sung-Hee Ihm, Sung Woo Park
      Diabetes & Metabolism Journal.2016; 40(5): 414.     CrossRef
    • Experiences of Diabetes Education among Educators of Diabetes : a content analysis approach
      Soo Jin Kang, Soo Jung Chang
      Journal of Korean Public Health Nursing.2016; 30(2): 221.     CrossRef
    • Efficient Strategy to Identify Gene-Gene Interactions and Its Application to Type 2 Diabetes
      Donghe Li, Sungho Won
      Genomics & Informatics.2016; 14(4): 160.     CrossRef
    • A patient-centric approach to optimise insulin therapy in Asia
      Su Yen Goh, Ernesto Ang, Shailendra Bajpai, Chaicharn Deerochanawong, Eun-Gyoung Hong, Zanariah Hussein, Shashank Joshi, Nor Azmi Kamaruddin, Sjoberg Kho, Alice Pik-Shan Kong, Chang Yu Pan, Riccardo Perfetti, Apichati Vichayanrat, Aleksandra Vlajnic, Juli
      Journal of Diabetes and its Complications.2016; 30(6): 973.     CrossRef
    • Glycosylated Hemoglobin Threshold for Predicting Diabetes and Prediabetes from the Fifth Korea National Health and Nutrition Examination Survey
      Sangmo Hong, Jun Goo Kang, Chul Sik Kim, Seong Jin Lee, Cheol-Young Park, Chang Beom Lee, Sung-Hee Ihm
      Diabetes & Metabolism Journal.2016; 40(2): 167.     CrossRef
    • Retrospective Observational Dose-Titration Study of Subjects with Type 2 Diabetes Mellitus with Inadequate Glycemic Control on 15 mg of Pioglitazone
      So Young Ha, Hae Won Jung, Yong Jun Choi, Hyun Kyo Lee, Jong Wook Choi, Ji Hoon Choi, Jung Hyun Noh, Jae Won Hong, Dong-Jun Kim
      The Journal of Korean Diabetes.2016; 17(1): 51.     CrossRef
    • Upper-normal waist circumference is a risk marker for metabolic syndrome in normal-weight subjects
      R. Okada, Y. Yasuda, K. Tsushita, K. Wakai, N. Hamajima, S. Matsuo
      Nutrition, Metabolism and Cardiovascular Diseases.2016; 26(1): 67.     CrossRef
    • Optimal Glycemic and Hemoglobin A1c Thresholds for Diagnosing Diabetes Based on Prevalence of Retinopathy in an Iranian Population
      Naser Samadi Aidenloo, Alireza Mehdizadeh, Neda Valizadeh, Mohammad Abbaszadeh, Siavash Qarequran, Hamidreza Khalkhali
      Iranian Red Crescent Medical Journal.2016;[Epub]     CrossRef
    • Trends of antidiabetic drug use in adult type 2 diabetes in Korea in 2002–2013
      Seung-Hyun Ko, Dae-Jung Kim, Jong-Heon Park, Cheol-Young Park, Chang Hee Jung, Hyuk-Sang Kwon, Joong-Yeol Park, Kee-Ho Song, Kyungdo Han, Ki-Up Lee, Kyung-Soo Ko
      Medicine.2016; 95(27): e4018.     CrossRef
    • Association between estimated blood glucose levels and glycated hemoglobin levels
      Seon-Ah Cha, Seung-Hyun Ko
      The Korean Journal of Internal Medicine.2016; 31(3): 457.     CrossRef
    • Uncontrolled diabetes mellitus: Prevalence and risk factors among people with type 2 diabetes mellitus in an Urban District of Karachi, Pakistan
      Fahad Javaid Siddiqui, Bilal Iqbal Avan, Sadia Mahmud, Debra J. Nanan, Abdul Jabbar, Pryseley Nkouibert Assam
      Diabetes Research and Clinical Practice.2015; 107(1): 148.     CrossRef
    • Assessment of glycemic control in patients with type 2 diabetes mellitus treated with metformin–sulfonylurea combination: Results of a multicenter, cross‐sectional, observational study in Korea
      Sin Gon Kim, Jong Ryeal Hahm, Duk Kyu Kim, Sung Rae Cho, Dong Seop Choi
      Journal of Diabetes Investigation.2015; 6(3): 317.     CrossRef
    • Avoiding or coping with severe hypoglycemia in patients with type 2 diabetes
      Jae-Seung Yun, Seung-Hyun Ko
      The Korean Journal of Internal Medicine.2015; 30(1): 6.     CrossRef
    • The Correlation between Hemoglobin A1c and Common Carotid Artery Intima Medial Thickness of Both Genders with Less Than 6.5% HbA1c Based on Ultrasound Measurement
      Yeongju Ryu, Youngjin Park, Byeong Jin Ye
      Korean Journal of Health Promotion.2015; 15(2): 47.     CrossRef
    • Increased prevalence of albuminuria in individuals with higher range of impaired fasting glucose: the 2011 Korea National Health and Nutrition Examination Survey
      Jong Chul Won, Jae Won Hong, Jung Min Kim, Tae Nyun Kim, Jung Hyun Noh, Kyung Soo Ko, Byoung Doo Rhee, Dong-Jun Kim
      Journal of Diabetes and its Complications.2015; 29(1): 50.     CrossRef
    • The Association between Chronic Kidney Disease and Diabetic Retinopathy: The Korea National Health and Nutrition Examination Survey 2008-2010
      Young-Hoon Park, Jeong Ah Shin, Jae-Hyung Han, Yong-Moon Park, Hyeon Woo Yim, Harald Mischak
      PLOS ONE.2015; 10(4): e0125338.     CrossRef
    • Efficacy of a New Medical Information system, Ubiquitous Healthcare Service with Voice Inception Technique in Elderly Diabetic Patients
      Kyoung Min Kim, Kyeong Seon Park, Hyun Ju Lee, Yun Hee Lee, Ji Seon Bae, Young Joon Lee, Sung Hee Choi, Hak Chul Jang, Soo Lim
      Scientific Reports.2015;[Epub]     CrossRef
    • Intensive Individualized Reinforcement Education Is Important for the Prevention of Hypoglycemia in Patients with Type 2 Diabetes
      Yun-Mi Yong, Kyung-Mi Shin, Kang-Min Lee, Jae-Young Cho, Sun-Hye Ko, Min-Hyang Yoon, Tae-Won Kim, Jong-Hyun Jeong, Yong-Moon Park, Seung-Hyun Ko, Yu-Bae Ahn
      Diabetes & Metabolism Journal.2015; 39(2): 154.     CrossRef
    • The Role of Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Understanding How Data Can Inform Clinical Practice in Korea
      Seungjoon Oh, Suk Chon, Kyu Jeong Ahn, In-Kyung Jeong, Byung-Joon Kim, Jun Goo Kang
      Diabetes & Metabolism Journal.2015; 39(3): 177.     CrossRef
    • Clinical Characteristics of Subjects with Sulfonylurea-Dependent Type 2 Diabetes
      Se Hee Min, Soo Heon Kwak, Young Min Cho, Kyong Soo Park, Hye Seung Jung
      Endocrinology and Metabolism.2015; 30(4): 509.     CrossRef
    • Cardiovascular Disease Predicts Severe Hypoglycemia in Patients with Type 2 Diabetes
      Jae-Seung Yun, Seung-Hyun Ko, Sun-Hye Ko, Ki-Ho Song, Ki-Dong Yoo, Kun-Ho Yoon, Yong-Moon Park, Yu-Bae Ahn
      Diabetes & Metabolism Journal.2015; 39(6): 498.     CrossRef
    • Association between flavonoid intake and diabetes risk among the Koreans
      Jee-Young Yeon, Yun Jung Bae, Eun-Young Kim, Eun-Ju Lee
      Clinica Chimica Acta.2015; 439: 225.     CrossRef
    • Association between Self-Reported Smoking and Hemoglobin A1c in a Korean Population without Diabetes: The 2011–2012 Korean National Health and Nutrition Examination Survey
      Jae Won Hong, Cheol Ryong Ku, Jung Hyun Noh, Kyung Soo Ko, Byoung Doo Rhee, Dong-Jun Kim, Barbara Fuhrman
      PLOS ONE.2015; 10(5): e0126746.     CrossRef
    • Relationship between metabolic syndrome and thyroid nodules in healthy Koreans
      Juyoung Shin, Min-Hee Kim, Kun-Ho Yoon, Moo-Il Kang, Bong-Yun Cha, Dong-Jun Lim
      The Korean Journal of Internal Medicine.2015; 31(1): 98.     CrossRef
    • Assessment of Cardiovascular Risk in Adults With Type 2 Diabetes and Metabolic Syndrome
      Chun-Ja Kim, Hee Sun Kang, Elizabeth A. Schlenk, Sun-Mi Chae
      The Diabetes Educator.2015; 41(2): 203.     CrossRef
    • Current Status of Management in Type 2 Diabetes Mellitus at General Hospitals in South Korea
      Jin-Hee Jung, Jung-Hwa Lee, Jin-Won Noh, Jeong-Eun Park, Hee-Sook Kim, Joo-Wha Yoo, Bok-Rye Song, Jeong-rim Lee, Myeong-Hee Hong, Hyang-Mi Jang, Young Na, Hyun-Joo Lee, Jeong-Mi Lee, Yang-Gyo Kang, Sun-Young Kim, Kang-Hee Sim
      Diabetes & Metabolism Journal.2015; 39(4): 307.     CrossRef
    • The number of metabolic syndrome components is a good risk indicator for both early- and late-stage kidney damage
      R. Okada, Y. Yasuda, K. Tsushita, K. Wakai, N. Hamajima, S. Matsuo
      Nutrition, Metabolism and Cardiovascular Diseases.2014; 24(3): 277.     CrossRef
    • Internet-Based Mentoring Program for Patients with Type 1 Diabetes
      Sun-Hye Ko, Seung-Hyun Ko
      Diabetes & Metabolism Journal.2014; 38(2): 107.     CrossRef
    • Association of Vitamin B12Deficiency and Metformin Use in Patients with Type 2 Diabetes
      Sun-Hye Ko, Sun-Hee Ko, Yu-Bae Ahn, Ki-Ho Song, Kyung-Do Han, Yong-Moon Park, Seung-Hyun Ko, Hye-Soo Kim
      Journal of Korean Medical Science.2014; 29(7): 965.     CrossRef
    • Plasma Glucose Regulation and Mortality in Korea: A Pooled Analysis of Three Community-Based Cohort Studies
      Nan Hee Kim, Dong-Jun Kim, Seok Won Park, Jee-Young Oh, Joong-Yeol Park, Chol Shin, Hong Kyu Lee, Yongsoo Park
      Diabetes & Metabolism Journal.2014; 38(1): 44.     CrossRef
    • The glycemic efficacies of insulin analogue regimens according to baseline glycemic status in Korean patients with type 2 diabetes: sub‐analysis from the A 1 chieve ® study
      Y.‐C. Hwang, J. G. Kang, K. J. Ahn, B. S. Cha, S.‐H. Ihm, S. Lee, M. Kim, B.‐W. Lee
      International Journal of Clinical Practice.2014; 68(11): 1338.     CrossRef
    • Higher Prevalence and Awareness, but Lower Control Rate of Hypertension in Patients with Diabetes than General Population: The Fifth Korean National Health and Nutrition Examination Survey in 2011
      Seung-Hyun Ko, Hyuk-Sang Kwon, Dae Jung Kim, Jae Hyeon Kim, Nan Hee Kim, Chul Sik Kim, Kee-Ho Song, Jong Chul Won, Soo Lim, Sung Hee Choi, Kyungdo Han, Yong-Moon Park, Bong-Yun Cha
      Diabetes & Metabolism Journal.2014; 38(1): 51.     CrossRef
    • Comparison between the Therapeutic Effect of Metformin, Glimepiride and Their Combination as an Add-On Treatment to Insulin Glargine in Uncontrolled Patients with Type 2 Diabetes
      Cheol-Young Park, Jun Goo Kang, Suk Chon, Junghyun Noh, Seung Joon Oh, Chang Beom Lee, Sung Woo Park, T. Mark Doherty
      PLoS ONE.2014; 9(3): e87799.     CrossRef
    • Glycaemic and haemoglobin A1c thresholds for detecting diabetic retinopathy: The fifth Korea National Health and Nutrition Examination Survey (2011)
      Yong-Moon Park, Seung-Hyun Ko, Jung-Min Lee, Dae-Jung Kim, Dong-Joon Kim, Kyungdo Han, Julie K. Bower, Yu-Bae Ahn
      Diabetes Research and Clinical Practice.2014; 104(3): 435.     CrossRef
    • Development of an HbA1c-Based Conversion Equation for Estimating Glycated Albumin in a Korean Population with a Wide Range of Glucose Intolerance
      Chang Hee Jung, You-Cheol Hwang, Kwang Joon Kim, Bong Soo Cha, Cheol-Young Park, Won Seon Jeon, Jae Hyeon Kim, Sang-Man Jin, Sang Youl Rhee, Jeong-taek Woo, Byung-Wan Lee, Sompop Bencharit
      PLoS ONE.2014; 9(4): e95729.     CrossRef
    • Risk of suicidal ideation in diabetes varies by diabetes regimen, diabetes duration, and HbA1c level
      Hoo-Yeon Lee, Myung-Il Hahm, Sang Gyu Lee
      Journal of Psychosomatic Research.2014; 76(4): 275.     CrossRef
    • Non-HDL cholesterol is an independent risk factor for aspirin resistance in obese patients with type 2 diabetes
      Jong Dai Kim, Cheol-Young Park, Kue Jeong Ahn, Jae Hyoung Cho, Kyung Mook Choi, Jun Goo Kang, Jae Hyeon Kim, Ki Young Lee, Byung Wan Lee, Ji Oh Mok, Min Kyong Moon, Joong Yeol Park, Sung Woo Park
      Atherosclerosis.2014; 234(1): 146.     CrossRef
    • Optimal glycated albumin cutoff value to diagnose diabetes in Korean adults: A retrospective study based on the oral glucose tolerance test
      You-Cheol Hwang, Chang Hee Jung, Hong-Yup Ahn, Won Seon Jeon, Sang-Man Jin, Jeong-taek Woo, Bong Soo Cha, Jae Hyeon Kim, Cheol-Young Park, Byung-Wan Lee
      Clinica Chimica Acta.2014; 437: 1.     CrossRef
    • Higher Prevalence of Metformin-Induced Vitamin B12 Deficiency in Sulfonylurea Combination Compared with Insulin Combination in Patients with Type 2 Diabetes: A Cross-Sectional Study
      Donghoon Kang, Jae-Seung Yun, Sun-Hye Ko, Tae-Seok Lim, Yu-Bae Ahn, Yong-Moon Park, Seung-Hyun Ko, Yu Wang
      PLoS ONE.2014; 9(10): e109878.     CrossRef
    • The Relationship between BMI and Glycated Albumin to Glycated Hemoglobin (GA/A1c) Ratio According to Glucose Tolerance Status
      Ji Hye Huh, Kwang Joon Kim, Byung-Wan Lee, Dong Wook Kim, Eun Seok Kang, Bong Soo Cha, Hyun Chul Lee, Marta Letizia Hribal
      PLoS ONE.2014; 9(2): e89478.     CrossRef
    • Prevalence of Diabetes and Prediabetes according to Fasting Plasma Glucose and HbA1c
      Ja Young Jeon, Seung-Hyun Ko, Hyuk-Sang Kwon, Nan Hee Kim, Jae Hyeon Kim, Chul Sik Kim, Kee-Ho Song, Jong Chul Won, Soo Lim, Sung Hee Choi, Myoung-jin Jang, Yuna Kim, Kyungwon Oh, Dae Jung Kim, Bong-Yun Cha
      Diabetes & Metabolism Journal.2013; 37(5): 349.     CrossRef
    • Metformin Based Dual-Combination Therapies in Drug Naïve Type 2 Diabetic Patients
      Dong-Lim Kim
      Diabetes & Metabolism Journal.2013; 37(6): 429.     CrossRef
    • Glycemic Effectiveness of Metformin-Based Dual-Combination Therapies with Sulphonylurea, Pioglitazone, or DPP4-Inhibitor in Drug-Naïve Korean Type 2 Diabetic Patients
      Young Ki Lee, Sun Ok Song, Kwang Joon Kim, Yongin Cho, Younjeong Choi, Yujung Yun, Byung-Wan Lee, Eun-Seok Kang, Bong Soo Cha, Hyun Chul Lee
      Diabetes & Metabolism Journal.2013; 37(6): 465.     CrossRef
    • Long-term changes of the prevalence and control rate of hypertension among Korean adults with diagnosed diabetes: 1998–2008 Korean National Health and Nutrition Examination Survey
      Seung-Hyun Ko, Hyuk-Sang Kwon, Ki-Ho Song, Yu-Bae Ahn, Kun-Ho Yoon, Hyeon Woo Yim, Won-Chul Lee, Yong-Moon Park
      Diabetes Research and Clinical Practice.2012; 97(1): 151.     CrossRef
    • Smoking and Type 2 Diabetes Mellitus
      Sang Ah Chang
      Diabetes & Metabolism Journal.2012; 36(6): 399.     CrossRef
    • Body Mass Index and Waist Circumference According to Glucose Tolerance Status in Korea: The 2005 Korean Health and Nutrition Examination Survey
      Hye Mi Kang, Dong-Jun Kim
      Journal of Korean Medical Science.2012; 27(5): 518.     CrossRef
    • Renal Hyperfiltration in Prediabetes Confirmed by Fasting Plasma Glucose and Hemoglobin A1c
      Rieko Okada, Kenji Wakai, Mariko Naito, Emi Morita, Sayo Kawai, Guang Yin, Noriyo Ozawa, Masatoshi Furuta, Erina Koyama, Rumi Tsuchiya, Noriko Kouno, Nobuyuki Hamajima
      Renal Failure.2012; 34(9): 1084.     CrossRef
    • Higher Morning to Evening Ratio in Total Dose of Twice-Daily Biphasic Insulin Analog Might Be Effective in Achieving Glucose Control in Patients with Poorly Controlled Type 2 Diabetes
      Yong-Ho Lee, Byung-Wan Lee, Hea Jin Kwon, Eun Seok Kang, Bong Soo Cha, Hyun Chul Lee
      Diabetes Technology & Therapeutics.2012; 14(6): 508.     CrossRef
    • The Risk of Bladder Cancer in Korean Diabetic Subjects Treated with Pioglitazone
      Sun Ok Song, Kwang Joon Kim, Byung-Wan Lee, Eun Seok Kang, Bong Soo Cha, Hyun Chul Lee
      Diabetes & Metabolism Journal.2012; 36(5): 371.     CrossRef
    • Low Density Lipoprotein Cholesterol Target Goal Attainment Rate and Physician Perceptions about Target Goal Achievement in Korean Patients with Diabetes
      Jenie Yoonoo Hwang, Chang Hee Jung, Woo Je Lee, Cheol Young Park, Sung Rae Kim, Kun-Ho Yoon, Moon Kyu Lee, Sung Woo Park, Joong-Yeol Park
      Diabetes & Metabolism Journal.2011; 35(6): 628.     CrossRef
    • Letter: Diabetic Polyneuropathy and Cardiovascular Complications in Type 2 Diabetic Patients (Diabetes Metab J 2011;35:390-6)
      Sun-Hye Ko, Seung-Hyun Ko
      Diabetes & Metabolism Journal.2011; 35(5): 558.     CrossRef

    • PubReader PubReader
    • Cite this Article
      Cite this Article
      export Copy Download
      Download Citation
      Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

      • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
      • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
      • Citation for the content below
      2011 Clinical Practice Guidelines for Type 2 Diabetes in Korea
      Diabetes Metab J. 2011;35(5):431-436.   Published online October 31, 2011
    • XML DownloadXML Download
    Related articles
    Ko SH, Kim SR, Kim DJ, Oh SJ, Lee HJ, Shim KH, Woo MH, Kim JY, Kim NH, Kim JT, Kim CH, Kim HJ, Jeong IK, Hong EK, Cho JH, Mok JO, Yoon KH, . 2011 Clinical Practice Guidelines for Type 2 Diabetes in Korea. Diabetes Metab J. 2011;35(5):431-436.

    Diabetes Metab J : Diabetes & Metabolism Journal
    Close layer